Global Plasma Fractionation and Blood Product Market Research Report 2024(Status and Outlook)
Report Overview:
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The Global Plasma Fractionation and Blood Product Market Size was estimated at USD 4946.10 million in 2023 and is projected to reach USD 5837.43 million by 2029, exhibiting a CAGR of 2.80% during the forecast period.
This report provides a deep insight into the global Plasma Fractionation and Blood Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Fractionation and Blood Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Fractionation and Blood Product market in any manner.
Global Plasma Fractionation and Blood Product Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Market Segmentation (by Type)
Coagulation Factor
Immune Globulin
Albumin
Other
Market Segmentation (by Application)
Immunology
Hematology
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Fractionation and Blood Product Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The Global Plasma Fractionation and Blood Product Market Size was estimated at USD 4946.10 million in 2023 and is projected to reach USD 5837.43 million by 2029, exhibiting a CAGR of 2.80% during the forecast period.
This report provides a deep insight into the global Plasma Fractionation and Blood Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Fractionation and Blood Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Fractionation and Blood Product market in any manner.
Global Plasma Fractionation and Blood Product Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Market Segmentation (by Type)
Coagulation Factor
Immune Globulin
Albumin
Other
Market Segmentation (by Application)
Immunology
Hematology
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Plasma Fractionation and Blood Product Market
- Overview of the regional outlook of the Plasma Fractionation and Blood Product Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Fractionation and Blood Product Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma Fractionation and Blood Product
1.2 Key Market Segments
1.2.1 Plasma Fractionation and Blood Product Segment by Type
1.2.2 Plasma Fractionation and Blood Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Fractionation and Blood Product Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024)
3.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Fractionation and Blood Product Sales Sites, Area Served, Product Type
3.6 Plasma Fractionation and Blood Product Market Competitive Situation and Trends
3.6.1 Plasma Fractionation and Blood Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA FRACTIONATION AND BLOOD PRODUCT INDUSTRY CHAIN ANALYSIS
4.1 Plasma Fractionation and Blood Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2024)
6.3 Global Plasma Fractionation and Blood Product Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Fractionation and Blood Product Price by Type (2019-2024)
7 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Fractionation and Blood Product Market Sales by Application (2019-2024)
7.3 Global Plasma Fractionation and Blood Product Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
8 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY REGION
8.1 Global Plasma Fractionation and Blood Product Sales by Region
8.1.1 Global Plasma Fractionation and Blood Product Sales by Region
8.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Fractionation and Blood Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Fractionation and Blood Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Fractionation and Blood Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Plasma Fractionation and Blood Product Basic Information
9.1.2 Takeda Plasma Fractionation and Blood Product Product Overview
9.1.3 Takeda Plasma Fractionation and Blood Product Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Fractionation and Blood Product SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Fractionation and Blood Product Basic Information
9.2.2 CSL Plasma Fractionation and Blood Product Product Overview
9.2.3 CSL Plasma Fractionation and Blood Product Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Fractionation and Blood Product SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma Fractionation and Blood Product Basic Information
9.3.2 Grifols Plasma Fractionation and Blood Product Product Overview
9.3.3 Grifols Plasma Fractionation and Blood Product Product Market Performance
9.3.4 Grifols Plasma Fractionation and Blood Product SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma Fractionation and Blood Product Basic Information
9.4.2 Octapharma Plasma Fractionation and Blood Product Product Overview
9.4.3 Octapharma Plasma Fractionation and Blood Product Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma Fractionation and Blood Product Basic Information
9.5.2 Kedrion Plasma Fractionation and Blood Product Product Overview
9.5.3 Kedrion Plasma Fractionation and Blood Product Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma Fractionation and Blood Product Basic Information
9.6.2 LFB Group Plasma Fractionation and Blood Product Product Overview
9.6.3 LFB Group Plasma Fractionation and Blood Product Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma Fractionation and Blood Product Basic Information
9.7.2 Biotest Plasma Fractionation and Blood Product Product Overview
9.7.3 Biotest Plasma Fractionation and Blood Product Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma Fractionation and Blood Product Basic Information
9.8.2 BPL Plasma Fractionation and Blood Product Product Overview
9.8.3 BPL Plasma Fractionation and Blood Product Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 RAAS
9.9.1 RAAS Plasma Fractionation and Blood Product Basic Information
9.9.2 RAAS Plasma Fractionation and Blood Product Product Overview
9.9.3 RAAS Plasma Fractionation and Blood Product Product Market Performance
9.9.4 RAAS Business Overview
9.9.5 RAAS Recent Developments
9.10 CBPO
9.10.1 CBPO Plasma Fractionation and Blood Product Basic Information
9.10.2 CBPO Plasma Fractionation and Blood Product Product Overview
9.10.3 CBPO Plasma Fractionation and Blood Product Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 Hualan Bio
9.11.1 Hualan Bio Plasma Fractionation and Blood Product Basic Information
9.11.2 Hualan Bio Plasma Fractionation and Blood Product Product Overview
9.11.3 Hualan Bio Plasma Fractionation and Blood Product Product Market Performance
9.11.4 Hualan Bio Business Overview
9.11.5 Hualan Bio Recent Developments
10 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET FORECAST BY REGION
10.1 Global Plasma Fractionation and Blood Product Market Size Forecast
10.2 Global Plasma Fractionation and Blood Product Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Fractionation and Blood Product Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Fractionation and Blood Product Market Size Forecast by Region
10.2.4 South America Plasma Fractionation and Blood Product Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Fractionation and Blood Product by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma Fractionation and Blood Product Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Fractionation and Blood Product by Type (2025-2030)
11.1.2 Global Plasma Fractionation and Blood Product Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Fractionation and Blood Product by Type (2025-2030)
11.2 Global Plasma Fractionation and Blood Product Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Fractionation and Blood Product Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma Fractionation and Blood Product Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma Fractionation and Blood Product
1.2 Key Market Segments
1.2.1 Plasma Fractionation and Blood Product Segment by Type
1.2.2 Plasma Fractionation and Blood Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Fractionation and Blood Product Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024)
3.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Fractionation and Blood Product Sales Sites, Area Served, Product Type
3.6 Plasma Fractionation and Blood Product Market Competitive Situation and Trends
3.6.1 Plasma Fractionation and Blood Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA FRACTIONATION AND BLOOD PRODUCT INDUSTRY CHAIN ANALYSIS
4.1 Plasma Fractionation and Blood Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2024)
6.3 Global Plasma Fractionation and Blood Product Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Fractionation and Blood Product Price by Type (2019-2024)
7 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Fractionation and Blood Product Market Sales by Application (2019-2024)
7.3 Global Plasma Fractionation and Blood Product Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
8 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET SEGMENTATION BY REGION
8.1 Global Plasma Fractionation and Blood Product Sales by Region
8.1.1 Global Plasma Fractionation and Blood Product Sales by Region
8.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Fractionation and Blood Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Fractionation and Blood Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Fractionation and Blood Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Plasma Fractionation and Blood Product Basic Information
9.1.2 Takeda Plasma Fractionation and Blood Product Product Overview
9.1.3 Takeda Plasma Fractionation and Blood Product Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Fractionation and Blood Product SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Fractionation and Blood Product Basic Information
9.2.2 CSL Plasma Fractionation and Blood Product Product Overview
9.2.3 CSL Plasma Fractionation and Blood Product Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Fractionation and Blood Product SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma Fractionation and Blood Product Basic Information
9.3.2 Grifols Plasma Fractionation and Blood Product Product Overview
9.3.3 Grifols Plasma Fractionation and Blood Product Product Market Performance
9.3.4 Grifols Plasma Fractionation and Blood Product SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma Fractionation and Blood Product Basic Information
9.4.2 Octapharma Plasma Fractionation and Blood Product Product Overview
9.4.3 Octapharma Plasma Fractionation and Blood Product Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma Fractionation and Blood Product Basic Information
9.5.2 Kedrion Plasma Fractionation and Blood Product Product Overview
9.5.3 Kedrion Plasma Fractionation and Blood Product Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma Fractionation and Blood Product Basic Information
9.6.2 LFB Group Plasma Fractionation and Blood Product Product Overview
9.6.3 LFB Group Plasma Fractionation and Blood Product Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma Fractionation and Blood Product Basic Information
9.7.2 Biotest Plasma Fractionation and Blood Product Product Overview
9.7.3 Biotest Plasma Fractionation and Blood Product Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma Fractionation and Blood Product Basic Information
9.8.2 BPL Plasma Fractionation and Blood Product Product Overview
9.8.3 BPL Plasma Fractionation and Blood Product Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 RAAS
9.9.1 RAAS Plasma Fractionation and Blood Product Basic Information
9.9.2 RAAS Plasma Fractionation and Blood Product Product Overview
9.9.3 RAAS Plasma Fractionation and Blood Product Product Market Performance
9.9.4 RAAS Business Overview
9.9.5 RAAS Recent Developments
9.10 CBPO
9.10.1 CBPO Plasma Fractionation and Blood Product Basic Information
9.10.2 CBPO Plasma Fractionation and Blood Product Product Overview
9.10.3 CBPO Plasma Fractionation and Blood Product Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 Hualan Bio
9.11.1 Hualan Bio Plasma Fractionation and Blood Product Basic Information
9.11.2 Hualan Bio Plasma Fractionation and Blood Product Product Overview
9.11.3 Hualan Bio Plasma Fractionation and Blood Product Product Market Performance
9.11.4 Hualan Bio Business Overview
9.11.5 Hualan Bio Recent Developments
10 PLASMA FRACTIONATION AND BLOOD PRODUCT MARKET FORECAST BY REGION
10.1 Global Plasma Fractionation and Blood Product Market Size Forecast
10.2 Global Plasma Fractionation and Blood Product Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Fractionation and Blood Product Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Fractionation and Blood Product Market Size Forecast by Region
10.2.4 South America Plasma Fractionation and Blood Product Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Fractionation and Blood Product by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma Fractionation and Blood Product Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Fractionation and Blood Product by Type (2025-2030)
11.1.2 Global Plasma Fractionation and Blood Product Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Fractionation and Blood Product by Type (2025-2030)
11.2 Global Plasma Fractionation and Blood Product Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Fractionation and Blood Product Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma Fractionation and Blood Product Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Fractionation and Blood Product Market Size Comparison by Region (M USD)
Table 5. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Fractionation and Blood Product Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2022)
Table 10. Global Market Plasma Fractionation and Blood Product Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma Fractionation and Blood Product Sales Sites and Area Served
Table 12. Manufacturers Plasma Fractionation and Blood Product Product Type
Table 13. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma Fractionation and Blood Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Fractionation and Blood Product Market Challenges
Table 22. Global Plasma Fractionation and Blood Product Sales by Type (Kilotons)
Table 23. Global Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 24. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Type (2019-2024)
Table 25. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2024)
Table 26. Global Plasma Fractionation and Blood Product Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma Fractionation and Blood Product Market Size Share by Type (2019-2024)
Table 28. Global Plasma Fractionation and Blood Product Price (USD/Ton) by Type (2019-2024)
Table 29. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Application
Table 30. Global Plasma Fractionation and Blood Product Market Size by Application
Table 31. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2024)
Table 33. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma Fractionation and Blood Product Market Share by Application (2019-2024)
Table 35. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Table 38. North America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Plasma Fractionation and Blood Product Basic Information
Table 44. Takeda Plasma Fractionation and Blood Product Product Overview
Table 45. Takeda Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Plasma Fractionation and Blood Product SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. CSL Plasma Fractionation and Blood Product Basic Information
Table 50. CSL Plasma Fractionation and Blood Product Product Overview
Table 51. CSL Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Plasma Fractionation and Blood Product SWOT Analysis
Table 54. CSL Recent Developments
Table 55. Grifols Plasma Fractionation and Blood Product Basic Information
Table 56. Grifols Plasma Fractionation and Blood Product Product Overview
Table 57. Grifols Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Plasma Fractionation and Blood Product SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Octapharma Plasma Fractionation and Blood Product Basic Information
Table 62. Octapharma Plasma Fractionation and Blood Product Product Overview
Table 63. Octapharma Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Kedrion Plasma Fractionation and Blood Product Basic Information
Table 67. Kedrion Plasma Fractionation and Blood Product Product Overview
Table 68. Kedrion Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kedrion Business Overview
Table 70. Kedrion Recent Developments
Table 71. LFB Group Plasma Fractionation and Blood Product Basic Information
Table 72. LFB Group Plasma Fractionation and Blood Product Product Overview
Table 73. LFB Group Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. LFB Group Business Overview
Table 75. LFB Group Recent Developments
Table 76. Biotest Plasma Fractionation and Blood Product Basic Information
Table 77. Biotest Plasma Fractionation and Blood Product Product Overview
Table 78. Biotest Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Biotest Business Overview
Table 80. Biotest Recent Developments
Table 81. BPL Plasma Fractionation and Blood Product Basic Information
Table 82. BPL Plasma Fractionation and Blood Product Product Overview
Table 83. BPL Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BPL Business Overview
Table 85. BPL Recent Developments
Table 86. RAAS Plasma Fractionation and Blood Product Basic Information
Table 87. RAAS Plasma Fractionation and Blood Product Product Overview
Table 88. RAAS Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. RAAS Business Overview
Table 90. RAAS Recent Developments
Table 91. CBPO Plasma Fractionation and Blood Product Basic Information
Table 92. CBPO Plasma Fractionation and Blood Product Product Overview
Table 93. CBPO Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. Hualan Bio Plasma Fractionation and Blood Product Basic Information
Table 97. Hualan Bio Plasma Fractionation and Blood Product Product Overview
Table 98. Hualan Bio Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Recent Developments
Table 101. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Plasma Fractionation and Blood Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Plasma Fractionation and Blood Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Plasma Fractionation and Blood Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Plasma Fractionation and Blood Product Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Plasma Fractionation and Blood Product Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Plasma Fractionation and Blood Product Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Plasma Fractionation and Blood Product Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Plasma Fractionation and Blood Product Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Fractionation and Blood Product Market Size Comparison by Region (M USD)
Table 5. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Fractionation and Blood Product Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2022)
Table 10. Global Market Plasma Fractionation and Blood Product Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma Fractionation and Blood Product Sales Sites and Area Served
Table 12. Manufacturers Plasma Fractionation and Blood Product Product Type
Table 13. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma Fractionation and Blood Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Fractionation and Blood Product Market Challenges
Table 22. Global Plasma Fractionation and Blood Product Sales by Type (Kilotons)
Table 23. Global Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 24. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Type (2019-2024)
Table 25. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2024)
Table 26. Global Plasma Fractionation and Blood Product Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma Fractionation and Blood Product Market Size Share by Type (2019-2024)
Table 28. Global Plasma Fractionation and Blood Product Price (USD/Ton) by Type (2019-2024)
Table 29. Global Plasma Fractionation and Blood Product Sales (Kilotons) by Application
Table 30. Global Plasma Fractionation and Blood Product Market Size by Application
Table 31. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2024)
Table 33. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma Fractionation and Blood Product Market Share by Application (2019-2024)
Table 35. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Table 38. North America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Plasma Fractionation and Blood Product Basic Information
Table 44. Takeda Plasma Fractionation and Blood Product Product Overview
Table 45. Takeda Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Plasma Fractionation and Blood Product SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. CSL Plasma Fractionation and Blood Product Basic Information
Table 50. CSL Plasma Fractionation and Blood Product Product Overview
Table 51. CSL Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Plasma Fractionation and Blood Product SWOT Analysis
Table 54. CSL Recent Developments
Table 55. Grifols Plasma Fractionation and Blood Product Basic Information
Table 56. Grifols Plasma Fractionation and Blood Product Product Overview
Table 57. Grifols Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Plasma Fractionation and Blood Product SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Octapharma Plasma Fractionation and Blood Product Basic Information
Table 62. Octapharma Plasma Fractionation and Blood Product Product Overview
Table 63. Octapharma Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Kedrion Plasma Fractionation and Blood Product Basic Information
Table 67. Kedrion Plasma Fractionation and Blood Product Product Overview
Table 68. Kedrion Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kedrion Business Overview
Table 70. Kedrion Recent Developments
Table 71. LFB Group Plasma Fractionation and Blood Product Basic Information
Table 72. LFB Group Plasma Fractionation and Blood Product Product Overview
Table 73. LFB Group Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. LFB Group Business Overview
Table 75. LFB Group Recent Developments
Table 76. Biotest Plasma Fractionation and Blood Product Basic Information
Table 77. Biotest Plasma Fractionation and Blood Product Product Overview
Table 78. Biotest Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Biotest Business Overview
Table 80. Biotest Recent Developments
Table 81. BPL Plasma Fractionation and Blood Product Basic Information
Table 82. BPL Plasma Fractionation and Blood Product Product Overview
Table 83. BPL Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BPL Business Overview
Table 85. BPL Recent Developments
Table 86. RAAS Plasma Fractionation and Blood Product Basic Information
Table 87. RAAS Plasma Fractionation and Blood Product Product Overview
Table 88. RAAS Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. RAAS Business Overview
Table 90. RAAS Recent Developments
Table 91. CBPO Plasma Fractionation and Blood Product Basic Information
Table 92. CBPO Plasma Fractionation and Blood Product Product Overview
Table 93. CBPO Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. Hualan Bio Plasma Fractionation and Blood Product Basic Information
Table 97. Hualan Bio Plasma Fractionation and Blood Product Product Overview
Table 98. Hualan Bio Plasma Fractionation and Blood Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Recent Developments
Table 101. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Plasma Fractionation and Blood Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Plasma Fractionation and Blood Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Plasma Fractionation and Blood Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Plasma Fractionation and Blood Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Plasma Fractionation and Blood Product Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Plasma Fractionation and Blood Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Plasma Fractionation and Blood Product Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Plasma Fractionation and Blood Product Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Plasma Fractionation and Blood Product Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Plasma Fractionation and Blood Product Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Plasma Fractionation and Blood Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Fractionation and Blood Product Market Size (M USD), 2019-2030
Figure 5. Global Plasma Fractionation and Blood Product Market Size (M USD) (2019-2030)
Figure 6. Global Plasma Fractionation and Blood Product Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Fractionation and Blood Product Market Size by Country (M USD)
Figure 11. Plasma Fractionation and Blood Product Sales Share by Manufacturers in 2023
Figure 12. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers in 2023
Figure 13. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma Fractionation and Blood Product Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma Fractionation and Blood Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma Fractionation and Blood Product Market Share by Type
Figure 18. Sales Market Share of Plasma Fractionation and Blood Product by Type (2019-2024)
Figure 19. Sales Market Share of Plasma Fractionation and Blood Product by Type in 2023
Figure 20. Market Size Share of Plasma Fractionation and Blood Product by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma Fractionation and Blood Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma Fractionation and Blood Product Market Share by Application
Figure 24. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Application in 2023
Figure 26. Global Plasma Fractionation and Blood Product Market Share by Application (2019-2024)
Figure 27. Global Plasma Fractionation and Blood Product Market Share by Application in 2023
Figure 28. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 32. U.S. Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Plasma Fractionation and Blood Product Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma Fractionation and Blood Product Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 37. Germany Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Region in 2023
Figure 44. China Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 50. South America Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 51. Brazil Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Plasma Fractionation and Blood Product Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Plasma Fractionation and Blood Product Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma Fractionation and Blood Product Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma Fractionation and Blood Product Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma Fractionation and Blood Product Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Plasma Fractionation and Blood Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Fractionation and Blood Product Market Size (M USD), 2019-2030
Figure 5. Global Plasma Fractionation and Blood Product Market Size (M USD) (2019-2030)
Figure 6. Global Plasma Fractionation and Blood Product Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Fractionation and Blood Product Market Size by Country (M USD)
Figure 11. Plasma Fractionation and Blood Product Sales Share by Manufacturers in 2023
Figure 12. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers in 2023
Figure 13. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma Fractionation and Blood Product Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma Fractionation and Blood Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma Fractionation and Blood Product Market Share by Type
Figure 18. Sales Market Share of Plasma Fractionation and Blood Product by Type (2019-2024)
Figure 19. Sales Market Share of Plasma Fractionation and Blood Product by Type in 2023
Figure 20. Market Size Share of Plasma Fractionation and Blood Product by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma Fractionation and Blood Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma Fractionation and Blood Product Market Share by Application
Figure 24. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Application in 2023
Figure 26. Global Plasma Fractionation and Blood Product Market Share by Application (2019-2024)
Figure 27. Global Plasma Fractionation and Blood Product Market Share by Application in 2023
Figure 28. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 32. U.S. Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Plasma Fractionation and Blood Product Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma Fractionation and Blood Product Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 37. Germany Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Region in 2023
Figure 44. China Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 50. South America Plasma Fractionation and Blood Product Sales Market Share by Country in 2023
Figure 51. Brazil Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Plasma Fractionation and Blood Product Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Plasma Fractionation and Blood Product Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Plasma Fractionation and Blood Product Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma Fractionation and Blood Product Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma Fractionation and Blood Product Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma Fractionation and Blood Product Market Share Forecast by Application (2025-2030)
